archetype (adl_version=1.4)
	openEHR-EHR-EVALUATION.tnm_breast_cancer_assessment.v1

concept
	[at0000]	-- Tnm breast cancer assessment
language
	original_language = <[ISO_639-1::en]>
	translations = <
		["sv"] = <
			language = <[ISO_639-1::sv]>
			author = <
				["name"] = <"?">
			>
		>
	>
description
	original_author = <
		["name"] = <"Syeeda S Farruque">
		["email"] = <"syeeda.farruque@cambiocds.com">
		["organisation"] = <"Cambio Healthcare Systems">
		["date"] = <"2017-06-15">
	>
	details = <
		["sv"] = <
			language = <[ISO_639-1::sv]>
			purpose = <"American Joint Committee on Cancers (AJCC) TNM-klassifikation beskriver allvarlighetsgrad av bröstcancer baserat på tumörstorlek, lymfkörtelengagemang och förekomst av metastaser.">
			use = <"Använd för stadieindelning av bröstcancer i enlighet med TNM-klassifikationen. Indelning sker efter kategori 0-4 med subgrupper inom respektive huvudkategori. Prognos uttrycks i 5-årsöverlevnad.
 
Stadium     5-årsöverlevnad           TNM                                 Beskrivning	                                                                                                                          
0                       99%                      
                                                Tis N0 M0            Carcinoma in situ. Varken regionalt lymfkörtelengagemang eller fjärrmetastaser har kunnat påvisas.
                                                                                                                                                     
I                        92%
                                                 T1 N0 M0           Tumör som störst 2 cm. Varken regionalt lymfkörtelengagemang eller fjärrmetastaser har kunnat påvisas.
                                                                                                                                                                
IIA                     82%
                                                 T0 N1 M0            Primärtumör har ej kunnat fastställas. Metastaser i regionala lymfkörtlar ipsilateralt. Ingen fjärrmetastasering påvisad.
                                                 T1 N1 M0            Tumören är som störst 2 cm. Metastaser i regionala lymfkörtlar ipsilateralt. Ingen fjärrmetastasering påvisad.
                                                 T2 N0 M0            Tumören är 2-5 cm. Varken regionalt lymfkörtelengagemang eller fjärrmetastaser har kunnat påvisas.
                                               
IIB                      65%                         
                                                  T2 N1 M0           Tumören är 2-5 cm. Metastaser i regionala lymfkörtlar ipsilateralt. Ingen fjärrmetastasering påvisad.                                                                                                               
                                                  T3 N0 M0           Tumören är större än 5 cm. Varken regionalt lymfkörtelengagemang eller fjärrmetastaser har kunnat påvisas.
                                                                             	                                    
IIIA                     47%                              
                                                   T0 N2 M0          Primärtumör har ej kunnat fastställas. Metastaser i fixerade (icke rörliga) regionala lymfkörtlar ipsilateralt. Ingen fjärrmetastasering påvisad.
                                                   T1 N2 M0          Tumören är som störst 2 cm. Metastaser i fixerade (icke rörliga) regionala lymfkörtlar ipsilateralt. Ingen fjärrmetastasering påvisad.
                                                   T2 N2 M0          Tumören är 2-5 cm. Metastaser i fixerade (icke rörliga) regionala lymfkörtlar ipsilateralt. Ingen fjärrmetastasering påvisad.
                                                   T3 N1-2 M0       Tumören är större än 5 cm. Metastaser i fixerade (icke rörliga) regionala lymfkörtlar ipsilateralt. Ingen fjärrmetastasering påvisad.	
IIIB                      44%                          
                                                    T4 N1-3 M0      •Tumören har invaderat bröstväggen. Regionalt lymfkörtelengagemang. Inga fjärrmetastaser har kunnat påvisas.
                                                    T1-4 N3 M0      •Oavsett tumörstorlek. Metastasering till ipsilaterala lymfkörtlar i bröstet.  Inga fjärrmetastaser har kunnat påvisas.
        	
IV                        14%                       
                                                    T1-4 N1-3 M1     Oavsett tumörstorlek eller grad av regionalt lymfkörtelengagemang. Fjärrmetastaser har påvisats.	


">
			keywords = <"*TNM breast cancer staging(en)", "*breast cancer(en)">
			misuse = <"TNM-klassifikation kräver data inhämtad med hjälp av högkvalitativa metoder inklusive bilddiagnostik och omfattande lymfkörtelundersökning. ">
			copyright = <"© Cambio Healthcare Systems">
		>
		["en"] = <
			language = <[ISO_639-1::en]>
			purpose = <"The American Joint Committee on Cancer (AJCC) TNM staging system reports on the severity of breast cancer based on tumor, lymph node and metastasis characteristics. The characteristics of the size of the tumour, the extent of spread to local lymph nodes and body organs. These aspects are captured in 3 ways that make up the mnemonic TNM: T: Tumour size; N: Number of regional lymph nodes affected and M: whether the cancer has spread/metastasised beyond the primary organ and regional nodes. Each major category is further subdivided to help classify the picture further. These subdivisions are given suffixes or numbered as shown below.">
			use = <"There are main stages Stage 0 to IV with each stage (except Stage 0) subdivided. Survival rates are shown below:
Stage	TNM	            Description	                                                                                                                          5-year Survival
0	Tis N0 M0             Carcinoma in situ. 
                                                  No tumor is regional lymph nodes, No distant metastases	                                                                           99%
I	T1 N0 M0	            Tumor is less than or equal to 2 centimeters, 
                                                  No tumor in regional lymph nodes, No distant metastases                                                                                            92%
IIA	T0 N1 M0              No evidence of primary tumor, metastases to movable ipsilateral nodes, 
                   T1 N1 M0              No distant metastases.
                   T2 N0 M0	            Tumor is less than or equal to 2 centimeters, metastases to movable ipsilateral    
                                                  nodes, No distant metastases.
                                                 Tumor is between 2 and 5 centimeters, No tumor in regional lymph nodes,
                                                 No distant metastases	                                                                                                                                                      82%
IIB	T2 N1 M0             Tumor is between 2 and 5 centimeters, metastases to movable ipsilateral nodes,
                   T3 N0 M0             No distant metastases.
                                                 Tumor is over 5 centimeters, No tumor in regional lymph nodes, No distant metastases.	                                      65%
IIIA	T0 N2 M0              No evidence of primary tumor, metastases to fixed ipsilateral nodes, no distant metastases.
                   T1 N2 M0             Tumor is less than or equal to 2 centimeters, metastases to fixed ipsilateral nodes, No distant metastases.
                   T2 N2 M0             Tumor is between 2 and 5 centimeters, metastases to fixed ipsilateral nodes, no distant metastases. 
                   T3 N1, N2 M0      Tumor is over 5 centimeters, metastases to movable or fixed ipsilateral nodes, no distant metastases.	47%
IIIB	T4 Any N M0
IIIC              Any T N3 M0      Tumor extends to chest wall, any nodal involvement, no distant metastases.
•	Any primary tumor involvement, metastases to ipsilateral internal mammary nodes, no distant metastases.	44%
IV	Any T Any N M1	Any primary tumor involvement, any nodal involvement, distant metastases.	14%


">
			keywords = <"TNM breast cancer staging", "breast cancer">
			misuse = <"Using the TNM classification alone is not recommended in providing diagnostic assessment. Clinical evidence is required to back up the staging suggestions. ">
			copyright = <"© Cambio Healthcare Systems">
		>
	>
	lifecycle_state = <"AuthorDraft">
	other_contributors = <>
	other_details = <
		["references"] = <"Ref. 1: AJCC Cancer Staging Atlas A Companion to the Seventh Editions of the AJCC Cancer Staging Manual and Handbook
Carolyn C. Compton David R Byrd; Julio Garcia-Aguilar; American Joint Committee on Cancer Content Provider. New York, NY : Springer New York : Imprint: Springer 2nd ed. 2012

Ref. 2: Theriault RL, Carlson RW, Allred C, et al. Breast Cancer, Version 3.2013: Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network : JNCCN. 2013;11(7):753-761.

Ref. 3: Regular updates for breast cancer staging and treeatment can be found on the NCCN  (National Comprehensive Cancer Network) website, accessed at: www.nccn.org

Ref. 4: Breast cancer survival rates: Cancer.org: https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/stages-of-breast-cancer.html">
		["MD5-CAM-1.0.1"] = <"35D05CAC27CA13B4D0CFBD566CCCDB7B">
	>

definition
	EVALUATION[at0000] matches {	-- Tnm breast cancer assessment
		data matches {
			ITEM_TREE[at0001] matches {	-- Tree
				items cardinality matches {0..*; unordered} matches {
					ELEMENT[at0002] occurrences matches {0..1} matches {	-- 5 Year Survival rates
						value matches {
							0|[local::at0003], 	-- 99% Stage 0
							1|[local::at0004], 	-- 92% Stage I
							2|[local::at0005], 	-- 82% Stage IIA
							3|[local::at0006], 	-- 65% Stage IIB
							4|[local::at0007], 	-- 47% Stage IIIA
							5|[local::at0008], 	-- 44% Stage IIIB
							6|[local::at0009], 	-- 14-44% Stage IIIc
							7|[local::at0010]  	-- 14% Stage IV
						}
					}
				}
			}
		}
	}

ontology
	term_definitions = <
		["en"] = <
			items = <
				["at0000"] = <
					text = <"Tnm breast cancer assessment">
					description = <"The American Joint Committee on Cancer (AJCC) TNM staging system reports on the severity of breast cancer based on tumor, lymph node and metastasis characteristics.">
				>
				["at0001"] = <
					text = <"Tree">
					description = <"@ internal @">
				>
				["at0002"] = <
					text = <"5 Year Survival rates">
					description = <"5 Year survival according to the Stage of breast cancer">
				>
				["at0003"] = <
					text = <"99% Stage 0">
					description = <"*">
				>
				["at0004"] = <
					text = <"92% Stage I">
					description = <"*">
				>
				["at0005"] = <
					text = <"82% Stage IIA">
					description = <"*">
				>
				["at0006"] = <
					text = <"65% Stage IIB">
					description = <"*">
				>
				["at0007"] = <
					text = <"47% Stage IIIA">
					description = <"*">
				>
				["at0008"] = <
					text = <"44% Stage IIIB">
					description = <"*">
				>
				["at0009"] = <
					text = <"14-44% Stage IIIc">
					description = <"*">
				>
				["at0010"] = <
					text = <"14% Stage IV">
					description = <"*">
				>
			>
		>
		["sv"] = <
			items = <
				["at0000"] = <
					text = <"TNM bröstcancer - utvärdering">
					description = <"American Joint Committee on Cancers (AJCC) TNM-klassifikation beskriver allvarlighetsgrad av bröstcancer baserat på tumörstorlek, lymfkörtelengagemang och förekomst av metastaser.">
				>
				["at0001"] = <
					text = <"*Tree(en)">
					description = <"*@ internal @(en)">
				>
				["at0002"] = <
					text = <"5-årsöverlevnad">
					description = <"5-årsöverlevnad baserat på stadieindelning.">
				>
				["at0003"] = <
					text = <"Stadium 0 - 99%">
					description = <"*">
				>
				["at0004"] = <
					text = <"Stadium I - 92%">
					description = <"*">
				>
				["at0005"] = <
					text = <"Stadium IIA - 82%">
					description = <"*">
				>
				["at0006"] = <
					text = <"Stadium IIB - 65%">
					description = <"*">
				>
				["at0007"] = <
					text = <"Stadium IIIA - 47%">
					description = <"*">
				>
				["at0008"] = <
					text = <"Stadium IIIB - 44%">
					description = <"*">
				>
				["at0009"] = <
					text = <"Stadium IV - 14%">
					description = <"*">
				>
				["at0010"] = <
					text = <"*new ordinal(en)">
					description = <"**(en)">
				>
			>
		>
	>
